RIABNI

Amgen Inc.

Application Filed: 2018-11-05
Trademark Application Details
Trademark Logo RIABNI

Mark For: RIABNI™ trademark registration is intended to cover the categories of pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation. [all]

Status

2021-01-22 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88182290
Mark Literal ElementsRIABNI
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-11-05
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameTimothy J. Gaul
Law Office AssignedL80
Employee NameBUSH, KAREN K

Timeline

2018-11-05Application Filed
2019-09-10Published
2019-09-10Published for Opposition
2019-11-05Location: INTENT TO USE SECTION
2019-11-05Status: Live/Pending
2019-11-05Transaction Date
2020-10-29Status: A second request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Amgen Inc.
AddressTrademark Operations - MS-28-5A One Amgen Center Drive Thousand Oaks, CALIFORNIA UNITED STATES 913201799
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2018-11-05
TEAS RF New ApplicationMULTI2018-11-05
XSearch Search SummaryXML2018-12-12
Notation to FileXML2018-12-13
Priority ActionXML2018-12-13
TEAS Rev, App and/or COA of Atty/Dom.RepXML2019-03-07
Examiners AmendmentXML2019-07-25
Amendment and Mail Process CompleteMULTI2019-07-26
TRAM Snapshot of App at Pub for OppostnMULTI2019-07-30
Notice of PublicationXML2019-08-21
Notification Of Notice of PublicationXML2019-08-21
OG Publication ConfirmationXML2019-09-10
Notice of AllowanceXML2019-11-05
Extension of Time to File SOUXML2020-04-28
ITU Extension ApprovalXML2020-04-30
ITU Unit ActionMULTI2020-04-30
Extension of Time to File SOUXML2020-10-29
ITU Extension ApprovalXML2020-10-31
ITU Unit ActionMULTI2020-11-02

Attorney of Record

Timothy J. Gaul
Amgen Inc.
One Amgen Center Drive
Trademark Operations
Thousand Oaks, CA 91320-1799

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-31
TEAS EXTENSION RECEIVED2020-10-29
EXTENSION 2 GRANTED2020-10-2998765
EXTENSION 2 FILED2020-10-2998765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-30
TEAS EXTENSION RECEIVED2020-04-28
EXTENSION 1 GRANTED2020-04-2898765
EXTENSION 1 FILED2020-04-2898765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-11-05
PUBLISHED FOR OPPOSITION2019-09-10
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-09-10
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-08-21
ASSIGNED TO LIE2019-08-0870633
APPROVED FOR PUB - PRINCIPAL REGISTER2019-07-29
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2019-07-256328
EXAMINERS AMENDMENT E-MAILED2019-07-256328
EXAMINERS AMENDMENT -WRITTEN2019-07-2567516
EXAMINER'S AMENDMENT ENTERED2019-07-2588888
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-03-07
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-03-07
PRIORITY ACTION WRITTEN2018-12-1367516
PRIORITY ACTION E-MAILED2018-12-136326
NOTIFICATION OF PRIORITY ACTION E-MAILED2018-12-136326
ASSIGNED TO EXAMINER2018-12-1167516
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-20
NEW APPLICATION ENTERED IN TRAM2018-11-08
© 2021 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed